GB Patent
GB0501956D0 — Nebulizer formulation
Assigned to Arrow International Ltd · Expires 2005-03-09 · 21y expired
What this patent protects
Patent listed against Yupelri.
Drugs covered by this patent
- Yupelri (REVEFENACIN) · Mylan Ireland Ltd
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.